Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
3.280
+0.050 (1.55%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $156.61 million as of October 2, 2026. Its market cap has increased by 965.39% in one year.
Market Cap
156.61M
Enterprise Value
141.34M
1-Year Change
965.39%
Ranking
Category
Stock Price
$3.28
ChartMarket Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $156.61M, an increase of 41.60%. That is a compound annual growth rate of 2.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 156.60M | 457.30% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 164.83M |
| Protara Therapeutics | 163.10M |
| Compass Therapeutics | 162.28M |
| Tonix Pharmaceuticals Holding | 158.30M |
| NovaBridge Biosciences | 155.44M |
| Molecular Partners AG | 154.03M |
| PepGen | 153.06M |
| Jyong Biotech | 150.69M |